HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data (Q32050110)

5 July 2017

1 reference

title

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data (English)

1 reference

5 July 2017

Crouse JR 3rd

1

1 reference

PubMed ID

9678767

5 July 2017

Byington RP

series ordinal

2

1 reference

PubMed ID

9678767

5 July 2017

Furberg CD

series ordinal

3

1 reference

5 July 2017

1 May 1998

1 reference

5 July 2017

1 reference

5 July 2017

138

1 reference

5 July 2017

1

1 reference

5 July 2017

11-24

1 reference

Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Progression of carotid atherosclerosis in Japanese patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Outcome in patients with asymptomatic neck bruits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Ultrasonographically assessed carotid morphology and the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Manifestations of coronary disease predisposing to stroke. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

A review of stroke epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Postoperative stroke in cardiac and peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Regional cerebral blood flow in familial hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Current status of risk factors for stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cerebrovascular Disease in the Bi-Racial Population of Evans County, Georgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Lipids and lipoproteins as predictors of coronary heart disease, stroke, and cancer in the Honolulu Heart Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Low blood cholesterol and non-atherosclerotic disease mortality: where do we stand?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Controlled trial of clofibrate in cerebral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

An overview of trials of cholesterol lowering and risk of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Prognostic importance of cholesterol levels after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Carotid stenosis in lacunar stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Minor asymptomatic carotid stenosis contralateral to carotid endarterectomy (CEA): Our experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

The natural history of asymptomatic carotid artery occlusive lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

The natural history of asymptomatic carotid artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Clinical follow-up rather than duplex surveillance after carotid endarterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Fate of the non-operated carotid artery after contralateral endarterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Infarcts of undetermined cause: the NINCDS Stroke Data Bank

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cerebrovascular accident complicating acute myocardial infarction: Incidence, clinical significance, and short-long-term mortality rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Stroke associated with cardiac surgery. Determinants, timing, and stroke subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Cerebral infarction in patients with transient ischemic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

A prospective reevaluation of transient ischemic attacks as a risk factor for death and fatal or nonfatal cardiovascular events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

Assessment and management of carotid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900014-8

10.1016/S0021-9150(98)00014-8

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

9678767